A Suicide Attempt Multicomponent Intervention Treatment (SAMIT Program): study protocol for a multicentric randomised controlled trial.
Intervention
Medically Serious Suicide Attempts (MSSA)
Psychotherapeutic intervention
Psychotherapy
Randomised controlled trial
Suicide attempt
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
received:
07
06
2024
accepted:
24
09
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
8
10
2024
Statut:
epublish
Résumé
Suicide has become a first-order public health concern, especially following the negative impact of COVID-19 on the mental health of the general population. Few studies have analysed the effects of early psychotherapeutic interventions on subjects who have attempted suicide, and even fewer have focused on those hospitalized in non-psychiatric units after a Medically Serious Suicide Attempt (MSSA). The main aim of this study is to describe the protocol designed to evaluate the effectiveness of individual psychological treatment for patients hospitalized after an MSSA. The secondary objectives of the study are: (1) to evaluate the impact on quality of life and other psychosocial variables of patients with a recent MSSA who receive early psychological intervention; (2) to analyse the biological, psychological, and clinical impact of early psychotherapeutic treatment on subjects hospitalized after an MSSA. A longitudinal randomised controlled trial will be conducted with patients over 16 years of age admitted to two general hospitals. The case intervention group will enrol for 8-sessions of individual psychotherapy, Suicide Attempts Multi-component Intervention Treatment (SAMIT), combining Dialectical Behaviour Therapy (DBT), Mentalization-Based Therapy (MBT), and Narrative approaches, while the control group will receive a treatment-as-usual intervention (TAU). Longitudinal assessment will be conducted at baseline (before treatment), post-treatment, and 3, 6, and 12 months after. The main outcome variable will be re-attempting suicide during follow-up. Some psychotherapeutic interventions, usually implemented in outpatient, have proven to be effective in preventing suicidal behaviours. The combination of some of these may be a powerful treatment for preventing future SA in patients hospitalised after an MSSA, which is the most severely suicidal subgroup. Moreover, assessment of the biological, clinical and psychometric impact of this new intervention on patients during the first year after the attempt may help understand some of the multi-level factors associated with the effectiveness of psychotherapeutic interventions in MSSAs. The prevalence of high suicide rates requires the design of effective psychological interventions for their prevention, and also in order to design new pharmacological and psychological treatments. ClinicalTrials.gov ID: NCT06238414. Date of registration: 1st February 2024, final update is protocol version 3.0, 19th March 2024.
Sections du résumé
BACKGROUND
BACKGROUND
Suicide has become a first-order public health concern, especially following the negative impact of COVID-19 on the mental health of the general population. Few studies have analysed the effects of early psychotherapeutic interventions on subjects who have attempted suicide, and even fewer have focused on those hospitalized in non-psychiatric units after a Medically Serious Suicide Attempt (MSSA). The main aim of this study is to describe the protocol designed to evaluate the effectiveness of individual psychological treatment for patients hospitalized after an MSSA. The secondary objectives of the study are: (1) to evaluate the impact on quality of life and other psychosocial variables of patients with a recent MSSA who receive early psychological intervention; (2) to analyse the biological, psychological, and clinical impact of early psychotherapeutic treatment on subjects hospitalized after an MSSA.
METHODS
METHODS
A longitudinal randomised controlled trial will be conducted with patients over 16 years of age admitted to two general hospitals. The case intervention group will enrol for 8-sessions of individual psychotherapy, Suicide Attempts Multi-component Intervention Treatment (SAMIT), combining Dialectical Behaviour Therapy (DBT), Mentalization-Based Therapy (MBT), and Narrative approaches, while the control group will receive a treatment-as-usual intervention (TAU). Longitudinal assessment will be conducted at baseline (before treatment), post-treatment, and 3, 6, and 12 months after. The main outcome variable will be re-attempting suicide during follow-up.
DISCUSSION
CONCLUSIONS
Some psychotherapeutic interventions, usually implemented in outpatient, have proven to be effective in preventing suicidal behaviours. The combination of some of these may be a powerful treatment for preventing future SA in patients hospitalised after an MSSA, which is the most severely suicidal subgroup. Moreover, assessment of the biological, clinical and psychometric impact of this new intervention on patients during the first year after the attempt may help understand some of the multi-level factors associated with the effectiveness of psychotherapeutic interventions in MSSAs. The prevalence of high suicide rates requires the design of effective psychological interventions for their prevention, and also in order to design new pharmacological and psychological treatments.
TRIAL REGISTRATION
BACKGROUND
ClinicalTrials.gov ID: NCT06238414. Date of registration: 1st February 2024, final update is protocol version 3.0, 19th March 2024.
Identifiants
pubmed: 39379877
doi: 10.1186/s12888-024-06113-3
pii: 10.1186/s12888-024-06113-3
doi:
Banques de données
ClinicalTrials.gov
['NCT06238414']
Types de publication
Journal Article
Clinical Trial Protocol
Randomized Controlled Trial
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
666Informations de copyright
© 2024. The Author(s).
Références
World Health Organization. Suicide worldwide in 2019: Global Health Estimates [Internet]. World Health Organization,Geneva. 2019. 4–9 p. https://apps.who.int/iris/rest/bitstreams/1350975/retrieve
Cerel J, Jordan JR, Duberstein PR. The impact of suicide on the family. Crisis. 2008;29(1):38–44.
pubmed: 18389644
doi: 10.1027/0227-5910.29.1.38
Pitman A, Osborn D, King M, Erlangsen A. Effects of suicide bereavement on mental health and suicide risk. Lancet Psychiatry. 2014;1(1):86–94.
pubmed: 26360405
doi: 10.1016/S2215-0366(14)70224-X
Chu C, Buchman-Schmitt JM, Stanley IH, Hom MA, Tucker RP, Hagan CR, et al. The interpersonal theory of suicide: a systematic review and meta-analysis of a decade of cross-national research. Psychol Bull. 2017;143(12):1313–45.
pubmed: 29072480
pmcid: 5730496
doi: 10.1037/bul0000123
INE. Defunciones según la Causa De Muerte. Notas De Prensa. 2021;2021:19.
Intituto Nacional de Estadística. Defunciones según la causa de muerte - año 2022 (datos provisionales). 2023;2022:1–6. https://www.ine.es/ss/Satellite?L=0&c=INECifrasINE_C&cid=1259954008107&p=1254735116567&pagename=Pr
Beneria A, Marte L, Quesada-Franco M, García-González S, Restoy D, Pérez-Galbarro C, et al. Trends in medically serious suicide attempts before and after the COVID-19: a four-year retrospective analysis [Preprint]. 2018–2022 [cited 2023 July 19] (Version 1). Available from: https://doi.org/10.21203/rs.3.rs-3093002/v1
Kawohl W, Nordt C. COVID-19, unemployment, and suicide. The lancet. Volume 7. Psychiatry. England; 2020. pp. 389–90.
Rogers SL, Cruickshank T. Change in mental health, physical health, and social relationships during highly restrictive lockdown in the COVID-19 pandemic: evidence from Australia. PeerJ. 2021;9:e11767.
pubmed: 34327055
pmcid: 8310621
doi: 10.7717/peerj.11767
Beautrais AL. Further suicidal behavior among medically serious suicide attempters. Suicide Life Threat Behav. 2004;34(1):1–11.
pubmed: 15106883
doi: 10.1521/suli.34.1.1.27772
Beautrais AL, Joyce PR, Mulder RT. Risk factors for serious suicide attempts among youths aged 13 through 24 years. J Am Acad Child Adolesc Psychiatry. 1996;35(9):1174–82.
pubmed: 8824061
doi: 10.1097/00004583-199609000-00015
Beautrais AL. Suicides and serious suicide attempts: two populations or one? Psychol Med. 2001;31(5):837–45.
pubmed: 11459381
doi: 10.1017/S0033291701003889
Beautrais AL. Suicide and serious suicide attempts in youth: a multiple-group comparison study. Am J Psychiatry. 2003;160(6):1093–9.
pubmed: 12777267
doi: 10.1176/appi.ajp.160.6.1093
Quesada-Franco M, Pintor-Pérez L, Daigre C, Baca-García E, Ramos-Quiroga JA, Braquehais MD. Medically serious suicide attempts in Personality disorders. J Clin Med. 2021;10:18.
doi: 10.3390/jcm10184186
Luoma JB, Martin CE, Pearson JL. Contact with mental health and primary care providers before suicide: a review of the evidence. Am J Psychiatry. 2002;159(6):909–16.
pubmed: 12042175
pmcid: 5072576
doi: 10.1176/appi.ajp.159.6.909
Owens C, Booth N, Briscoe M, Lawrence C, Lloyd K. Suicide outside the care of mental health services: a case-controlled psychological autopsy study. Crisis. 2003;24(3):113–21.
pubmed: 14518644
doi: 10.1027//0227-5910.24.3.113
Hamdi E, Price S, Qassem T, Amin Y, Jones D. Suicides not in contact with mental health services: Risk indicators and determinants of referral. J Ment Heal [Internet]. 2008;17(4):398–409. https://doi.org/10.1080/09638230701506234
Cleary A. Suicidal action, emotional expression, and the performance of masculinities. Soc Sci Med. 2012;74(4):498–505.
pubmed: 21930333
doi: 10.1016/j.socscimed.2011.08.002
O’Brien R, Hunt K, Hart G. ‘It’s caveman stuff, but that is to a certain extent how guys still operate’: men’s accounts of masculinity and help seeking. Soc Sci Med [Internet]. 2005;61(3):503–16. https://www.sciencedirect.com/science/article/pii/S0277953605000031
Van Orden KA, Witte TK, Cukrowicz KC, Braithwaite SR, Selby EA, Joiner TEJ. The interpersonal theory of suicide. Psychol Rev. 2010;117(2):575–600.
pubmed: 20438238
pmcid: 3130348
doi: 10.1037/a0018697
Joiner TEJ, Brown JS, Wingate LR. The psychology and neurobiology of suicidal behavior. Annu Rev Psychol. 2005;56:287–314.
pubmed: 15709937
doi: 10.1146/annurev.psych.56.091103.070320
Galynker I, Yaseen ZS, Cohen A, Benhamou O, Hawes M, Briggs J. Prediction of suicidal behavior in high risk psychiatric patients using an assessment of acute suicidal state: the suicide crisis inventory. Depress Anxiety. 2017;34(2):147–58.
pubmed: 27712028
doi: 10.1002/da.22559
Cohen L, Mokhtar R, Richards J, Hernandez M, Bloch-Elkouby S, Galynker I. The Narrative-Crisis Model of suicide and its prediction of near‐term suicide risk. Suicide Life-Threatening Behav. 2021;52.
Gilbert P, Gilbert J. Entrapment and arrested fight and flight in depression: an exploration using focus groups. Psychol Psychother. 2003;76(Pt 2):173–88.
pubmed: 12855063
doi: 10.1348/147608303765951203
Li S, Galynker II, Briggs J, Duffy M, Frechette-Hagan A, Kim HJ, et al. Attachment style and suicide behaviors in high risk psychiatric inpatients following hospital discharge: the mediating role of entrapment. Psychiatry Res. 2017;257:309–14.
pubmed: 28797954
doi: 10.1016/j.psychres.2017.07.072
Capuzzi E, Caldiroli A, Capellazzi M, Tagliabue I, Buoli M, Clerici M. Biomarkers of suicidal behaviors: a comprehensive critical review. Adv Clin Chem. 2020;96:179–216.
pubmed: 32362318
doi: 10.1016/bs.acc.2019.11.005
Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci [Internet]. 2003;4(10):819–28. https://doi.org/10.1038/nrn1220
Mann JJ. The serotonergic system in mood disorders and suicidal behaviour. Philos Trans R Soc Lond Ser B Biol Sci. 2013;368(1615):20120537.
doi: 10.1098/rstb.2012.0537
Boulougouris V, Malogiannis I, Lockwood G, Zervas I, Di Giovanni G. Serotonergic modulation of suicidal behaviour: integrating preclinical data with clinical practice and psychotherapy. Exp Brain Res. 2013;230(4):605–24.
pubmed: 23975151
doi: 10.1007/s00221-013-3669-z
Fernández-Sevillano J, González-Pinto A, Rodríguez-Revuelta J, Alberich S, Gónzalez-Blanco L, Zorrilla I, et al. Suicidal behaviour and cognition: a systematic review with special focus on prefrontal deficits. J Affect Disord. 2021;278:488–96.
pubmed: 33017675
doi: 10.1016/j.jad.2020.09.044
Fernández-Sevillano J, Alberich S, Zorrilla I, González-Ortega I, López MP, Pérez V, et al. Cognition in recent suicide attempts: altered executive function. Front Psychiatry. 2021;12:701140.
pubmed: 34366931
pmcid: 8339467
doi: 10.3389/fpsyt.2021.701140
Fernández-Sevillano J, González-Ortega I, MacDowell K, Zorrilla I, López MP, Courtet P, et al. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition. World J Biol Psychiatry off J World Fed Soc Biol Psychiatry. 2022;23(4):307–17.
doi: 10.1080/15622975.2021.1988703
Schiweck C, Valles-Colomer M, Arolt V, Müller N, Raes J, Wijkhuijs A, et al. Depression and suicidality: a link to premature T helper cell aging and increased Th17 cells. Brain Behav Immun. 2020;87:603–9.
pubmed: 32061905
doi: 10.1016/j.bbi.2020.02.005
Lindqvist D, Janelidze S, Erhardt S, Träskman-Bendz L, Engström G, Brundin L. CSF biomarkers in suicide attempters–a principal component analysis. Acta Psychiatr Scand. 2011;124(1):52–61.
pubmed: 21198458
doi: 10.1111/j.1600-0447.2010.01655.x
Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, et al. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun. 2011;25(6):1272–8.
pubmed: 21605657
pmcid: 3468945
doi: 10.1016/j.bbi.2011.05.002
Bryleva EY, Brundin L. Kynurenine pathway metabolites and suicidality. Neuropharmacology. 2017;112(Pt B):324–30.
pubmed: 26820800
doi: 10.1016/j.neuropharm.2016.01.034
Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A, Neacsiu AD, et al. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry. 2015;72(5):475–82.
pubmed: 25806661
doi: 10.1001/jamapsychiatry.2014.3039
Yang X, Liu D, Wang Y, Chen Y, Chen W, Yang C, et al. Effectiveness of Zhong-Yong thinking based dialectical behavior therapy group skills training versus supportive group therapy for lowering suicidal risks in Chinese young adults: a randomized controlled trial with a 6-month follow-up. Brain Behav. 2020;10(6):e01621.
pubmed: 32304353
pmcid: 7303376
doi: 10.1002/brb3.1621
Bryan CJ, Rozek DC. Suicide prevention in the military: a mechanistic perspective. Curr Opin Psychol. 2018;22:27–32.
pubmed: 30122274
doi: 10.1016/j.copsyc.2017.07.022
Conner KR, Kearns JC, Esposito EC, Pizzarello E, Wiegand TJ, Britton PC, et al. Pilot RCT of the Attempted Suicide Short Intervention Program (ASSIP) adapted for rapid delivery during hospitalization to adult suicide attempt patients with substance use problems. Gen Hosp Psychiatry. 2021;72:66–72.
pubmed: 34304029
pmcid: 8448954
doi: 10.1016/j.genhosppsych.2021.07.002
Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K. A novel brief therapy for patients who attempt suicide: a 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP). PLoS Med. 2016;13(3):e1001968.
pubmed: 26930055
pmcid: 4773217
doi: 10.1371/journal.pmed.1001968
Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2012;51(12):1304–e13133.
pubmed: 23200287
doi: 10.1016/j.jaac.2012.09.018
Griffiths H, Duffy F, Duffy L, Brown S, Hockaday H, Eliasson E, et al. Efficacy of Mentalization-based group therapy for adolescents: the results of a pilot randomised controlled trial. BMC Psychiatry. 2019;19(1):167.
pubmed: 31170947
pmcid: 6554935
doi: 10.1186/s12888-019-2158-8
Bateman A, Fonagy P. Mentalization based treatment for borderline personality disorder. World Psychiatry. 2010;9(1):11–5.
pubmed: 20148147
pmcid: 2816926
doi: 10.1002/j.2051-5545.2010.tb00255.x
Riblet NB, Shiner B, Schnurr P, Bruce ML, Wasserman D, Cornelius S, et al. A pilot study of an intervention to prevent suicide after Psychiatric hospitalization. J Nerv Ment Dis. 2019;207(12):1031–8.
pubmed: 31688286
pmcid: 8801296
doi: 10.1097/NMD.0000000000001061
Chan A-W, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
pubmed: 23303884
pmcid: 3541470
doi: 10.1136/bmj.e7586
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
doi: 10.1016/j.jbi.2019.103208
Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972;34(2):187–202.
doi: 10.1111/j.2517-6161.1972.tb00899.x
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, text revision. Washington, DC: American Psychiatric Association; 2022.
doi: 10.1176/appi.books.9780890425787
Bateman A, Fonagy P. Grupo introducción a la MBT (MBT-I). In: Bateman A, Fonagy P, editors. Tratamiento basado en la mentalización para Los trastornos de personalidad. Una guía práctica. 2nd ed. UK. Desclée de Brower; 2016. pp. 417–87.
Bateman A, Fonagy P. Mentalization-Based Treatment for Personality Disorders: A Practical Guide [Internet]. Oxford University Press; 2016. https://doi.org/10.1093/med:psych/9780199680375.001.0001
Linehan M. Skills Training Manual for Treating Borderline Personality Disorder, First Ed [Internet]. Guilford Publications; 1993. (Diagnosis and Treatment of Mental Disorders). https://books.google.es/books?id=iCM6BAAAQBAJ
Mentalizing and Emergency Care. In pp. 364–87. https://www.cambridge.org/core/product/6B976C284C38BCD60B7A026A9398ED59
Karsen E, Cohen LJ, White B, De GP, Goncearencoa I, Galynker II et al. Impact of the abbreviated suicide Crisis Syndrome Checklist on clinical decision making in the Emergency Department. J Clin Psychiatry. 2023;84(3).
Kar N, Arun M, Mohanty MK, Bastia BK. Scale for assessment of lethality of suicide attempt. Indian J Psychiatry. 2014;56(4):337–43.
pubmed: 25568473
pmcid: 4279290
doi: 10.4103/0019-5545.146512
Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266–77.
pubmed: 22193671
pmcid: 3893686
doi: 10.1176/appi.ajp.2011.10111704
Beck RW, Morris JB, Beck AT. Cross-validation of the suicidal intent scale. Psychol Rep. 1974;34(2):445–6.
pubmed: 4820501
doi: 10.2466/pr0.1974.34.2.445
Beck AT, Steer RA, Ranieri WF. Scale for suicide ideation: psychometric properties of a self-report version. J Clin Psychol. 1988;44(4):499–505.
pubmed: 3170753
doi: 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6
Burckhardt CS, Anderson KL, Archenholtz B, Hägg O. The flanagan quality of life scale: evidence of construct validity. Health Qual Life Outcomes. 2003;1(59):1–7. https://doi.org/10.1186/1477-7525-1-59 .
Shneidman ES. The psychological pain assessment scale. Suicide Life Threat Behav. 1999;29(4):287–94.
pubmed: 10636323
doi: 10.1111/j.1943-278X.1999.tb00524.x
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.
pubmed: 6880820
doi: 10.1111/j.1600-0447.1983.tb09716.x
Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;42(6):861–5.
pubmed: 4436473
doi: 10.1037/h0037562
Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768–74.
pubmed: 8778124
doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
Ruiz-Parra E, Manzano-García G, Mediavilla R, Rodríguez-Vega B, Lahera G, Moreno-Pérez AI, et al. The Spanish version of the reflective functioning questionnaire: validity data in the general population and individuals with personality disorders. PLoS ONE. 2023;18(4):e0274378.
pubmed: 37023214
pmcid: 10079014
doi: 10.1371/journal.pone.0274378
Balluerka N, Lacasa F, Gorostiaga A, Muela A, Pierrehumbert B. Versión reducida del cuestionario CaMir (CaMir-R) para la evaluación del apego. Psicothema. 2011;23(3):486–94.
pubmed: 21774904